Press Release
Press Release
The market for meningococcal vaccines is being driven by the growing public health awareness and initiatives undertaken by the government to help safeguard children of various age-groups from getting infected by meningococcal disease. The market is further aided by the rising number of individuals becoming conscious regarding the symptoms, and the effect of meningococcal meningitis and its subsequent treatment options, especially in the worst-hit regions. Moreover, the rising access to meningococcal vaccines in the developing regions, like in some African countries, by the support of global organisations, which have been helping with the vaccine prequalification, procurement, and funding, is facilitating the market growth of meningococcal vaccines.
The rising competition among the industry key players like Pfizer Inc. (NYSE: PFE) and Sanofi SA is providing impetus to the market growth. In June 2020, Pfizer Inc. announced the beginning of four phase 3 clinical trials for investigational vaccines, including the pentavalent meningococcal vaccine candidate, MenABCWY, in both adolescents and young adults to determine the safety, tolerability, and immunogenicity of MenABCWY vaccine candidate, in comparison to the licensed meningococcal vaccines. This will help determine the immunologic noninferiority of the candidate. Such ongoing research and development in the pharmaceutical industry are expected to stimulate the market growth over the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global market for meningococcal vaccines is being driven by the growing initiatives like National Immunization Programs (NIPs) by the government with the support of private non-profit organisations for the formation of meningococcal vaccines.
Pfizer Inc., Sanofi SA, GlaxoSmithKline plc, and Incepta Vaccine Ltd., among others, are the key players in the global meningococcal vaccines market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.